Home > Research > Publications & Outputs > The Molecular Virology of Coronaviruses with Sp...

Links

Text available via DOI:

View graph of relations

The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2

Research output: Contribution in Book/Report/Proceedings - With ISBN/ISSNChapter

Published

Standard

The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2. / Clayton, E.; Rohaim, M.A.; Bayoumi, M. et al.
Coronavirus Therapeutics – Volume I : Basic Science and Therapy Development. ed. / Alexzander A.A. Asea; Punit Kaur. Cham: Springer, 2022. p. 15-31 (Advances in Experimental Medicine and Biology; Vol. 1352).

Research output: Contribution in Book/Report/Proceedings - With ISBN/ISSNChapter

Harvard

Clayton, E, Rohaim, MA, Bayoumi, M & Munir, M 2022, The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2. in AAA Asea & P Kaur (eds), Coronavirus Therapeutics – Volume I : Basic Science and Therapy Development. Advances in Experimental Medicine and Biology, vol. 1352, Springer, Cham, pp. 15-31. https://doi.org/10.1007/978-3-030-85109-5_2

APA

Clayton, E., Rohaim, M. A., Bayoumi, M., & Munir, M. (2022). The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2. In A. A. A. Asea, & P. Kaur (Eds.), Coronavirus Therapeutics – Volume I : Basic Science and Therapy Development (pp. 15-31). (Advances in Experimental Medicine and Biology; Vol. 1352). Springer. https://doi.org/10.1007/978-3-030-85109-5_2

Vancouver

Clayton E, Rohaim MA, Bayoumi M, Munir M. The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2. In Asea AAA, Kaur P, editors, Coronavirus Therapeutics – Volume I : Basic Science and Therapy Development. Cham: Springer. 2022. p. 15-31. (Advances in Experimental Medicine and Biology). doi: 10.1007/978-3-030-85109-5_2

Author

Clayton, E. ; Rohaim, M.A. ; Bayoumi, M. et al. / The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2. Coronavirus Therapeutics – Volume I : Basic Science and Therapy Development. editor / Alexzander A.A. Asea ; Punit Kaur. Cham : Springer, 2022. pp. 15-31 (Advances in Experimental Medicine and Biology).

Bibtex

@inbook{5ff3cc89ebd34869ad190d08eca1f9d3,
title = "The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2",
abstract = "Introduction: Coronaviruses (CoVs) are large, enveloped and positive-sense RNA viruses which are responsible for a range of upper respiratory and digestive tract infections. Interest in coronaviruses has recently escalated due to the identification of a newly emerged coronavirus named severe acute respiratory syndrome 2 (SARS-CoV-2), which is the causative agent of the COVID-19 pandemic. In this chapter, we summarise molecular virological features of coronaviruses and understand their molecular mechanisms of replication in guiding the control of the global COVID-19 pandemic.Methods: We applied a holistic and comparative approach to assess the current understanding of coronavirus molecular virology and identify research gaps among different human coronaviruses.Results: Coronaviruses can utilise unique strategies that aid in their pathogenicity, replication and survival in multiple hosts. Replication of coronaviruses involves novel mechanisms such as ribosomal frameshifting and the synthesis of both genomic and sub-genomic RNAs. We summarised the key components in coronavirus molecular biology and molecular determinants of pathogenesis. Focusing largely on SARS-CoV-2 due to its current importance, this review explores the virology of recently emerged coronaviruses to gain an in-depth understanding of these infectious diseases.Conclusions: The presented information provides fundamental bottlenecks to devise future disease control and management strategies to curtail the impact of coronaviruses in human populations.",
keywords = "human, pandemic, COVID-19, Humans, Pandemics, SARS-CoV-2",
author = "E. Clayton and M.A. Rohaim and M. Bayoumi and M. Munir",
year = "2022",
month = feb,
day = "7",
doi = "10.1007/978-3-030-85109-5_2",
language = "English",
isbn = "9783030851088",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer",
pages = "15--31",
editor = "Asea, {Alexzander A.A.} and Punit Kaur",
booktitle = "Coronavirus Therapeutics – Volume I",

}

RIS

TY - CHAP

T1 - The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2

AU - Clayton, E.

AU - Rohaim, M.A.

AU - Bayoumi, M.

AU - Munir, M.

PY - 2022/2/7

Y1 - 2022/2/7

N2 - Introduction: Coronaviruses (CoVs) are large, enveloped and positive-sense RNA viruses which are responsible for a range of upper respiratory and digestive tract infections. Interest in coronaviruses has recently escalated due to the identification of a newly emerged coronavirus named severe acute respiratory syndrome 2 (SARS-CoV-2), which is the causative agent of the COVID-19 pandemic. In this chapter, we summarise molecular virological features of coronaviruses and understand their molecular mechanisms of replication in guiding the control of the global COVID-19 pandemic.Methods: We applied a holistic and comparative approach to assess the current understanding of coronavirus molecular virology and identify research gaps among different human coronaviruses.Results: Coronaviruses can utilise unique strategies that aid in their pathogenicity, replication and survival in multiple hosts. Replication of coronaviruses involves novel mechanisms such as ribosomal frameshifting and the synthesis of both genomic and sub-genomic RNAs. We summarised the key components in coronavirus molecular biology and molecular determinants of pathogenesis. Focusing largely on SARS-CoV-2 due to its current importance, this review explores the virology of recently emerged coronaviruses to gain an in-depth understanding of these infectious diseases.Conclusions: The presented information provides fundamental bottlenecks to devise future disease control and management strategies to curtail the impact of coronaviruses in human populations.

AB - Introduction: Coronaviruses (CoVs) are large, enveloped and positive-sense RNA viruses which are responsible for a range of upper respiratory and digestive tract infections. Interest in coronaviruses has recently escalated due to the identification of a newly emerged coronavirus named severe acute respiratory syndrome 2 (SARS-CoV-2), which is the causative agent of the COVID-19 pandemic. In this chapter, we summarise molecular virological features of coronaviruses and understand their molecular mechanisms of replication in guiding the control of the global COVID-19 pandemic.Methods: We applied a holistic and comparative approach to assess the current understanding of coronavirus molecular virology and identify research gaps among different human coronaviruses.Results: Coronaviruses can utilise unique strategies that aid in their pathogenicity, replication and survival in multiple hosts. Replication of coronaviruses involves novel mechanisms such as ribosomal frameshifting and the synthesis of both genomic and sub-genomic RNAs. We summarised the key components in coronavirus molecular biology and molecular determinants of pathogenesis. Focusing largely on SARS-CoV-2 due to its current importance, this review explores the virology of recently emerged coronaviruses to gain an in-depth understanding of these infectious diseases.Conclusions: The presented information provides fundamental bottlenecks to devise future disease control and management strategies to curtail the impact of coronaviruses in human populations.

KW - human

KW - pandemic

KW - COVID-19

KW - Humans

KW - Pandemics

KW - SARS-CoV-2

U2 - 10.1007/978-3-030-85109-5_2

DO - 10.1007/978-3-030-85109-5_2

M3 - Chapter

SN - 9783030851088

T3 - Advances in Experimental Medicine and Biology

SP - 15

EP - 31

BT - Coronavirus Therapeutics – Volume I

A2 - Asea, Alexzander A.A.

A2 - Kaur, Punit

PB - Springer

CY - Cham

ER -